NCT03937453View on ClinicalTrials.gov

A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus

RecruitingOBSERVATIONAL

Enrollment

800

Participants

Timeline

Start Date

January 19, 2018

Primary Completion Date

January 19, 2028

Study Completion Date

January 19, 2028

Conditions

Pancreatic CancerPancreatic Neoplasms

Interventions

DIAGNOSTIC_TEST

MRI/MRCP

An MRI/MRCP with IV gadolinium contrast with high resolution imaging of the pancreas will be performed at baseline. Further imaging upon recommendation by study committee

Trial Locations (1)

06856

RECRUITING

Nuvance Health, Norwalk